Anondita Medicare Limited IPO Review
Neutral137-137 · SME
✦
Analyst Verdict
Anondita Medicare Limited IPO
Neutral
IPO at a Glance
Price Band
137-137
Issue Size
69cr
Min. Investment
₹1,37,000
Opens
2025-08-20
Closes
2025-08-24
Listing
2025-08-30
Category
SME
Key Strengths
✓Established brand presence with flagship “COBRA” condoms.
✓Long-standing relationships with distributors and institutional buyers.
✓Wide product portfolio in the sexual wellness segment.
✓In-house quality testing ensures global compliance standards.
✓Experienced promoters with three decades of industry knowledge.
Key Risks
⚠High dependence on limited customers for revenues.
⚠Majority revenue concentrated from sale of condoms.
⚠Exposure to government tender-based order fluctuations.
⚠Subject to strict regulatory and quality requirements.
⚠Foreign exchange fluctuations impacting export revenues.
Frequently Asked Questions
Should I apply for Anondita Medicare Limited IPO?
Based on our analysis, our rating for Anondita Medicare Limited IPO is: Neutral. Review the full analysis including strengths, risks, and financials on CheckIPO before making a decision.
What are the key risks of Anondita Medicare Limited IPO?
High dependence on limited customers for revenues. Majority revenue concentrated from sale of condoms. Exposure to government tender-based order fluctuations.
What are the strengths of Anondita Medicare Limited IPO?
Established brand presence with flagship “COBRA” condoms. Long-standing relationships with distributors and institutional buyers. Wide product portfolio in the sexual wellness segment.
What is the price band of Anondita Medicare Limited IPO?
The price band for Anondita Medicare Limited IPO is 137-137. The IPO has closed.
Full Analysis Available
Financials, DRHP breakdown, peer comparison, shareholding pattern & more